{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:12:14Z","timestamp":1794557534109,"version":"4.9.1"},"reference-count":334,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Human papillomavirus (HPV), a common sexually transmitted virus infecting mucosal or cutaneous stratified epithelia, is implicated in the rising of associated cancers worldwide. While HPV infection can be cleared by an adequate immune response, immunocompromised individuals can develop persistent, treatment-refractory, and progressive disease. Primary immunodeficiencies (PIDs) associated with HPV-related disease include inborn errors of GATA, EVER1\/2, and CXCR4 mutations, resulting in defective cellular function. People living with secondary immunodeficiency (e.g. solid-organ transplants recipients of immunosuppression) and acquired immunodeficiency (e.g. concurrent human immunodeficiency virus (HIV) infection) are also at significant risk of HPV-related disease. Immunocompromised people are highly susceptible to the development of cutaneous and mucosal warts, and cervical, anogenital and oropharyngeal carcinomas. The specific mechanisms underlying high-risk HPV-driven cancer development in immunocompromised hosts are not well understood. Current treatments for HPV-related cancers include surgery with adjuvant chemotherapy and\/or radiotherapy, with clinical trials underway to investigate the use of anti-PD-1 therapy. In the setting of HIV co-infection, persistent high-grade anal intraepithelial neoplasia can occur despite suppressive antiretroviral therapy, resulting in an ongoing risk for transformation to overt malignancy. Although therapeutic vaccines against HPV are under development, the efficacy of these in the setting of PID, secondary- or acquired- immunodeficiencies remains unclear. RNA-based therapeutic targeting of the HPV genome or mRNA transcript has become a promising next-generation therapeutic avenue. In this review, we summarise the current understanding of HPV pathogenesis, immune evasion, and malignant transformation, with a focus on key PIDs, secondary immunodeficiencies, and HIV infection. Current management and vaccine regimes are outlined in relation to HPV-driven cancer, and specifically, the need for more effective therapeutic strategies for immunocompromised hosts. The recent advances in RNA-based gene targeting including CRISPR and short interfering RNA (siRNA), and the potential application to HPV infection are of great interest. An increased understanding of both the dysregulated immune responses in immunocompromised hosts and of viral persistence is essential for the design of next-generation therapies to eliminate HPV persistence and cancer development in the most at-risk populations.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1112513","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:17:35Z","timestamp":1678148255000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":123,"title":["Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk"],"prefix":"10.3389","volume":"14","author":[{"given":"Rehana V.","family":"Hewavisenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantelle L.","family":"Ahlenstiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Sasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis","volume":"8","author":"De Martel","year":"2020","journal-title":"Lancet Global Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2007.12.005","article-title":"Viruses associated with human cancer","volume":"1782","author":"McLaughlin-Drubin","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.08.040","article-title":"Secondary immunodeficiencies, including hiv infection","volume":"125","author":"Chinen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/v6104047","article-title":"Cancer issue: Viruses and human cancer","volume":"79","author":"Liao","year":"2006","journal-title":"Yale J Biol Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"De Villiers","year":"2004","journal-title":"Virology"},{"key":"B7","article-title":"Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients","volume":"54","author":"Shamanin","year":"1994","journal-title":"Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.12.802","article-title":"Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients","volume":"88","author":"Shamanin","year":"1996","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B9","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1016\/j.vaccine.2013.10.003","article-title":"Comprehensive control of human papillomavirus infections and related diseases","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.4.1026","article-title":"Human papillomavirus infection is transient in young women: A population-based cohort study","volume":"171","author":"Evander","year":"1995","journal-title":"J Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"key":"B12","article-title":"Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects","volume":"62","author":"De Jong","year":"2002","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24804","article-title":"A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of Hpv16 E2-, E6- and E7-specific T-cell responses","volume":"126","author":"Woo","year":"2010","journal-title":"Int J Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.soc.2016.07.010","article-title":"Human immunodeficiency Virus\/Aids, human papillomavirus, and anal cancer","volume":"26","author":"Wang","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.8.1031","article-title":"Incidence of cervical squamous intraepithelial lesions in hiv-infected women","volume":"283","author":"Ellerbrock","year":"2000","journal-title":"Jama"},{"key":"B16","article-title":"Human papillomavirus and lower genital neoplasia in renal transplant patients","volume":"68","author":"Halpert","year":"1986","journal-title":"Obstet Gynecol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11904-014-0254-4","article-title":"Human papillomavirus in the hiv-infected host: Epidemiology and pathogenesis in the antiretroviral era","volume":"12","author":"Brickman","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1159\/000357907","article-title":"Human papillomavirus and immunosuppression","volume":"45","author":"Wieland","year":"2014","journal-title":"Curr Probl Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0085","article-title":"Opportunities and challenges: Human papillomavirus and cancer","volume":"15","author":"Chu","year":"2017","journal-title":"J Natl Compr Cancer Netw"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30947","article-title":"Five-year relative survival for human papillomavirus-associated cancer sites","volume":"124","author":"Razzaghi","year":"2018","journal-title":"Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.67.9613","article-title":"Hiv infection and survival among women with cervical cancer","volume":"34","author":"Dryden-Peterson","year":"2016","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200412150-00004","article-title":"Hiv-associated anal cancer: Has highly active antiretroviral therapy reduced the incidence or improved the outcome","volume":"37","author":"Bower","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/olq.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the united states","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33628","article-title":"Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030","volume":"127","author":"Wu","year":"2021","journal-title":"Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B27","unstructured":"Hpv and cancer: National cancer intitute2023"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90044-5","article-title":"Acquisition of immunologic self-tolerance","volume":"57","author":"Schwartz","year":"1989","journal-title":"Cell"},{"key":"B29","volume-title":"Human papillomaviruses","year":"2007"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0053-6","article-title":"Nationwide comprehensive human papillomavirus (Hpv) genotyping of invasive cervical cancer","volume":"118","author":"Lagheden","year":"2018","journal-title":"Br J Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/v13071326","article-title":"A contemporary systematic review on repartition of hpv-positivity in oropharyngeal cancer worldwide","volume":"13","author":"Carlander","year":"2021","journal-title":"Viruses"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204162","article-title":"Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2018","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30682-x","article-title":"Prevalence of human papillomavirus DNA and P16(Ink4a) in penile cancer and penile intraepithelial neoplasia: A systematic review and meta-analysis","volume":"20","author":"Olesen","year":"2019","journal-title":"Lancet Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2010.01.016","article-title":"Beyond cervical cancer: Burden of other hpv-related cancers among men and women","volume":"46","author":"Chaturvedi","year":"2010","journal-title":"J Adolesc Health"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.10.024","article-title":"Risk factors for and prevention of human papillomaviruses (Hpv), genital warts and cervical cancer","volume":"66","author":"Chelimo","year":"2013","journal-title":"J Infect"},{"key":"B37","article-title":"Human Papillomaviruses. Lyon (FR): International Agency for Research on Cancer; 2007. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 90.) 5, Summary of Data Reported and Evaluation","year":"2007"},{"key":"B38","article-title":"Personal Habits and Indoor Combustions. Lyon (FR): International Agency for Research on Cancer; 2012. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100E.)","year":"2012","journal-title":"TOBACCO SMOKING"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082201","article-title":"High-risk human papillomavirus and tobacco smoke interactions in epithelial carcinogenesis","volume":"12","author":"Aguayo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140700","article-title":"Alcohol and tobacco increases risk of high risk hpv infection in head and neck cancer patients: Study from north-East region of India","volume":"10","author":"Kumar","year":"2015","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21493","article-title":"Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies","volume":"118","author":"Appleby","year":"2006","journal-title":"Int J Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1071\/sh12070","article-title":"The epidemiology of anal cancer","volume":"9","author":"Grulich","year":"2012","journal-title":"Sex Health"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03022","article-title":"Tobacco exposure enhances human papillomavirus 16 oncogene expression Via Egfr\/Pi3k\/Akt\/C-jun signaling pathway in cervical cancer cells","volume":"9","author":"Mu\u00f1oz","year":"2018","journal-title":"Front Microbiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)08151-5","article-title":"Role of parity and human papillomavirus in cervical cancer: The iarc multicentric case-control study","volume":"359","author":"Mu\u00f1oz","year":"2002","journal-title":"Lancet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/17455065221075904","article-title":"High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case-control studies","volume":"18","author":"Tekalegn","year":"2022","journal-title":"Womens Health (Lond)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The iarc multicentric case-control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.contraception.2021.10.018","article-title":"The relationship between hormonal contraception and cervical Dysplasia\/Cancer controlling for human papillomavirus infection: A systematic review","volume":"107","author":"Anastasiou","year":"2022","journal-title":"Contraception"},{"key":"B48","article-title":"Vitamin a, carotenoids, and risk of persistent oncogenic human papillomavirus infection","volume":"11","author":"Sedjo","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2020.1841251","article-title":"Association of diet quality and dietary components with clinical resolution of hpv","volume":"73","author":"Naresh","year":"2021","journal-title":"Nutr Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910340306","article-title":"Dietary vitamin a and the risk of invasive cervical cancer","volume":"34","author":"La Vecchia","year":"1984","journal-title":"Int J Cancer"},{"key":"B51","article-title":"Antioxidant nutrients: Associations with persistent human papillomavirus infection","volume":"6","author":"Giuliano","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/01635589809514639","article-title":"Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions","volume":"30","author":"Palan","year":"1998","journal-title":"Nutr Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(91)90039-c","article-title":"The effect of beta-carotene on the regression and progression of cervical dysplasia: A clinical experiment","volume":"44","author":"De Vet","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2006.12.002","article-title":"Lower red blood cell folate enhances the hpv-16-Associated risk of cervical intraepithelial neoplasia","volume":"23","author":"Piyathilake","year":"2007","journal-title":"Nutrition"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.Capr-14-0143","article-title":"Folate and vitamin B12 may play a critical role in lowering the hpv 16 methylation-associated risk of developing higher grades of cin","volume":"7","author":"Piyathilake","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(92)91337-a","article-title":"Oral folic acid supplementation for cervical dysplasia: A clinical intervention trial","volume":"166","author":"Butterworth","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"B57","article-title":"Chemoprevention of cervical cancer with folic acid: A phase iii southwest oncology group intergroup study","volume":"4","author":"Childers","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13223-018-0290-5","article-title":"Primary immunodeficiency","volume":"14","author":"McCusker","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.789345","article-title":"High prevalence of genital human papillomavirus infection in patients with primary immunodeficiencies","volume":"12","author":"Gernert","year":"2021","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4020260","article-title":"Hpv carcinomas in immunocompromised patients","volume":"4","author":"Reusser","year":"2015","journal-title":"J Clin Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2741\/1971","article-title":"Papillomavirus genome structure, expression, and post-transcriptional regulation","volume":"11","author":"Zheng","year":"2006","journal-title":"Front Biosci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1159\/000214919","article-title":"Human papillomaviruses: Genetic basis of carcinogenicity","volume":"12","author":"Burk","year":"2009","journal-title":"Public Health Genomics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"17991","DOI":"10.1038\/s41598-020-75133-2","article-title":"Use of cap analysis gene expression to detect human papillomavirus promoter activity patterns at different disease stages","volume":"10","author":"Taguchi","year":"2020","journal-title":"Sci Rep"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2016.12.017","article-title":"The low-risk papillomaviruses","volume":"231","author":"Egawa","year":"2017","journal-title":"Virus Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.07.018","article-title":"Human papillomavirus genome variants","volume":"445","author":"Burk","year":"2013","journal-title":"Virology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (Pvs) based on 189 pv types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.31557\/apjcp.2018.19.12.3361","article-title":"Phylogeny and classification of human papillomavirus (Hpv)16 and Hpv18 variants based on E6 and L1 genes in Tunisian women with cervical lesions","volume":"19","author":"Jendoubi-Ferchichi","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"B68","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/s1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and hiv status: A systematic review and meta-analysis","volume":"18","author":"Lin","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: From basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.083","article-title":"The biology and life-cycle of human papillomaviruses","volume":"30","author":"Doorbar","year":"2012","journal-title":"Vaccine"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.5.927","article-title":"The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women","volume":"174","author":"Carter","year":"1996","journal-title":"J Infect Dis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: Role of persistence","volume":"102","author":"Kj\u00e6r","year":"2010","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2013.09.001","article-title":"Hpv and hpv-associated diseases","volume":"27","author":"Dunne","year":"2013","journal-title":"Infect Dis Clin North Am"},{"key":"B74","article-title":"Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells","volume":"48","author":"von Knebel Doeberitz","year":"1988","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90529-8","article-title":"Degradation of P53 can be targeted by hpv E6 sequences distinct from those required for P53 binding and trans-activation","volume":"67","author":"Crook","year":"1991","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203244","article-title":"The retinoblastoma gene family in differentiation and development","volume":"18","author":"Lipinski","year":"1999","journal-title":"Oncogene"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.75.16.7583-7591.2001","article-title":"Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7","volume":"75","author":"Gonzalez","year":"2001","journal-title":"J Virol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.170093297","article-title":"The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability","volume":"62","author":"Duensing","year":"2002","journal-title":"Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/QAD.0000000000000254","article-title":"Incidence of and risk factors for type-specific anal human papillomavirus infection among hiv-positive msm","volume":"28","author":"Hernandez","year":"2014","journal-title":"AIDS (Lond Engl)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pvr.2017.08.002","article-title":"Modulation of antigen presenting cell functions during chronic hpv infection","volume":"4","author":"Bashaw","year":"2017","journal-title":"Papillomavirus Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.16","article-title":"Vaccines for established cancer: Overcoming the challenges posed by immune evasion","volume":"16","author":"van der Burg","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1086\/315706","article-title":"Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens","volume":"182","author":"Nakagawa","year":"2000","journal-title":"J Infect Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23210","article-title":"Human papillomavirus E7 oncoprotein expression by keratinocytes alters the cytotoxic mechanisms used by Cd8 T cells","volume":"9","author":"Bhat","year":"2018","journal-title":"Oncotarget"},{"key":"B84","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2567.2010.03277.x","article-title":"Cd4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix","volume":"131","author":"Seresini","year":"2010","journal-title":"Immunology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00262-011-1092-5","article-title":"Cd4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend","volume":"61","author":"Kim","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05028-11","article-title":"Epithelial cell responses to infection with human papillomavirus","volume":"25","author":"Stanley","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22015","article-title":"Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus","volume":"119","author":"Koshiol","year":"2006","journal-title":"Int J Cancer"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-4179","article-title":"A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia","volume":"70","author":"Schiffman","year":"2010","journal-title":"Cancer Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.26.3.769","article-title":"Hla genes and other candidate genes involved in susceptibility for (Pre) neoplastic cervical disease","volume":"26","author":"Zoodsma","year":"2005","journal-title":"Int J Oncol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23459","article-title":"Selected class I and class ii hla alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia","volume":"122","author":"Ades","year":"2008","journal-title":"Int J Cancer"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2021.200212","article-title":"Harnessing immunity for therapy in human papillomavirus driven cancers","volume":"11","author":"Stern","year":"2021","journal-title":"Tumour Virus Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102297","article-title":"Role of the Jak\/Stat pathway in cervical cancer: Its relationship with hpv E6\/E7 oncoproteins","volume":"9","author":"Guti\u00e9rrez-Hoya","year":"2020","journal-title":"Cells"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1306","article-title":"Stat3\/Irf1 pathway activation sensitizes cervical cancer cells to chemotherapeutic drugs","volume":"76","author":"Walch-R\u00fcckheim","year":"2016","journal-title":"Cancer Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/0008-5472.CAN-10-2193","article-title":"Molecular pathobiology of human cervical high-grade lesions: Paracrine Stat3 activation in tumor-instructed myeloid cells drives local mmp-9 expression","volume":"71","author":"Schr\u00f6er","year":"2011","journal-title":"Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28549","article-title":"Cervical cancer cell-derived interleukin-6 impairs Ccr7-dependent migration of mmp-9 expressing dendritic cells","volume":"134","author":"Pahne-Zeppenfeld","year":"2014","journal-title":"Int J Cancer"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.5.6.661","article-title":"Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1","volume":"5","author":"Perea","year":"2000","journal-title":"Int J Mol Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(01)00871-0","article-title":"Abrogation of irf-1 response by high-risk hpv E7 protein in vivo","volume":"179","author":"Um","year":"2002","journal-title":"Cancer Lett"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgn145","article-title":"Silencing of E7 oncogene restores functional e-cadherin expression in human papillomavirus 16-transformed keratinocytes","volume":"29","author":"Caberg","year":"2008","journal-title":"Carcinogenesis"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.15.8378-8385.2003","article-title":"Depletion of langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of e-cadherin","volume":"77","author":"Matthews","year":"2003","journal-title":"J Virol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017848","article-title":"Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes","volume":"6","author":"Karim","year":"2011","journal-title":"PloS One"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8100095","article-title":"Functional roles of E6 and E7 oncoproteins in hpv-induced malignancies at diverse anatomical sites","volume":"8","author":"Tomai\u0107","year":"2016","journal-title":"Cancers (Basel)"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31829e9fb4","article-title":"Multiple-type human papillomavirus (Hpv) infections: A cross-sectional analysis of the prevalence of specific types in 309,000 women referred for hpv testing at the time of cervical cytology","volume":"23","author":"Dickson","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.049","article-title":"Warts and all: Human papillomavirus in primary immunodeficiencies","volume":"130","author":"Leiding","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-020-02183-x","article-title":"Human genetic dissection of papillomavirus-driven diseases: New insight into their pathogenesis","volume":"139","author":"B\u00e9ziat","year":"2020","journal-title":"Hum Genet"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104348","article-title":"Development of a B-hpv vaccine: Updates on an emerging frontier of skin cancer prevention","volume":"126","author":"Gupta","year":"2020","journal-title":"J Clin Virol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/ng1044","article-title":"Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis","volume":"32","author":"Ramoz","year":"2002","journal-title":"Nat Genet"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00033-08","article-title":"The ever proteins as a natural barrier against papillomaviruses: A new insight into the pathogenesis of human papillomavirus infections","volume":"73","author":"Lazarczyk","year":"2009","journal-title":"Microbiol Mol Biol Rev"},{"key":"B108","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.20071311","article-title":"Regulation of cellular zinc balance as a potential mechanism of ever-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses","volume":"205","author":"Lazarczyk","year":"2008","journal-title":"J Exp Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23377","article-title":"Cutaneous human papillomavirus infection, the Ever2 gene and incidence of squamous cell carcinoma: A case-control study","volume":"122","author":"Patel","year":"2008","journal-title":"Int J Cancer"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/10552","article-title":"Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis","volume":"5","author":"Moore","year":"1999","journal-title":"Nat Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.27","article-title":"Ever2 protein binds tradd to promote tnf-A-Induced apoptosis","volume":"4","author":"Gaud","year":"2013","journal-title":"Cell Death Dis"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01057","article-title":"The role of interleukin 6 during viral infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front Microbiol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","article-title":"Il-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines4030022","article-title":"The il-8\/Il-8r axis: A double agent in tumor immune resistance","volume":"4","author":"David","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2011.402","article-title":"Influence of interleukin-8 (Il-8) and il-8 receptors on the migration of human keratinocytes, the role of plc-\u0393 and potential clinical implications","volume":"3","author":"Jiang","year":"2012","journal-title":"Exp Ther Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/imr.12719","article-title":"Whim syndrome: Immunopathogenesis, treatment and cure strategies","volume":"287","author":"McDermott","year":"2019","journal-title":"Immunol Rev"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e32831ac557","article-title":"Whim syndrome: Congenital immune deficiency disease","volume":"16","author":"Kawai","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02109","article-title":"The chemokine receptor Cxcr4 in cell proliferation and tissue regeneration","volume":"11","author":"Bianchi","year":"2020","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1023\/b:hijo.0000032355.66152.b8","article-title":"Cxcr4\u2013Sdf-1 signalling, locomotion, chemotaxis and adhesion","volume":"35","author":"Kucia","year":"2004","journal-title":"J Mol Histol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.13.1699","article-title":"The chemokine sdf-l\u03b1 triggers Cxcr4 receptor dimerization and activates the Jak\/Stat pathway","volume":"13","author":"Vila-Coro","year":"1999","journal-title":"FASEB J"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2289","article-title":"Whim syndromes with different genetic anomalies are accounted for by impaired Cxcr4 desensitization to Cxcl12","volume":"105","author":"Balabanian","year":"2005","journal-title":"Blood"},{"key":"B122","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/blood-2007-07-102103","article-title":"Cxcr4 dimerization and B-Arrestin\u2013mediated signaling account for the enhanced chemotaxis to Cxcl12 in whim syndrome","volume":"112","author":"Lagane","year":"2008","journal-title":"Blood J Am Soc Hematol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006039","article-title":"The Cxcl12\/Cxcr4 signaling pathway: A new susceptibility factor in human papillomavirus pathogenesis","volume":"12","author":"Meuris","year":"2016","journal-title":"PloS Pathog"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-419","article-title":"Involvement of tumor necrosis factor-alpha in the upregulation of Cxcr4 expression in gastric cancer induced by helicobacter pylori","volume":"10","author":"Zhao","year":"2010","journal-title":"BMC Cancer"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3390\/v9090261","article-title":"Mechanisms by which hpv induces a replication competent environment in differentiating keratinocytes","volume":"9","author":"Moody","year":"2017","journal-title":"Viruses"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905506","article-title":"Combined immunodeficiency associated with Dock8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"New Engl J Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/archdermatol.2011.262","article-title":"Cutaneous manifestations of Dock8 deficiency syndrome","volume":"148","author":"Chu","year":"2012","journal-title":"Arch Dermatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3233\/DMA-2010-0737","article-title":"Genetic, clinical, and laboratory markers for Dock8 immunodeficiency syndrome","volume":"29","author":"Zhang","year":"2010","journal-title":"Dis Markers"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94275","article-title":"Dock8 regulates fitness and function of regulatory T cells through modulation of il-2 signaling","volume":"2","author":"Singh","year":"2017","journal-title":"JCI Insight"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1236","article-title":"Dock8 deficiency diminishes thymic T-regulatory cell development but not thymic deletion","volume":"10","author":"Randall","year":"2021","journal-title":"Clin Trans Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211011951","article-title":"Dock8 serves as a prognostic biomarker and is related to immune infiltration in patients with hpv positive head and neck squamous cell carcinoma","volume":"28","author":"Zhang","year":"2021","journal-title":"Cancer Control"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0211-7","article-title":"Expanded skin virome in Dock8-deficient patients","volume":"24","author":"Tirosh","year":"2018","journal-title":"Nat Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028449","article-title":"The common cytokine receptor \u0393 chain family of cytokines","volume":"10","author":"Lin","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(04)16457-x","article-title":"Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or jak-3 deficiency","volume":"363","author":"Laffort","year":"2004","journal-title":"Lancet"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.024","article-title":"Absence of \u0393-chain in keratinocytes alters chemokine secretion, resulting in reduced immune cell recruitment","volume":"137","author":"Nowak","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260124","article-title":"Expression of the common cytokine receptor \u0393 chain by murine dendritic cells including epidermal langerhans cells","volume":"26","author":"Mohamadzadeh","year":"1996","journal-title":"Eur J Immunol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ebiom.2017.12.022","article-title":"Langerhans cells prevent autoimmunity Via expansion of keratinocyte antigen-specific regulatory T cells","volume":"27","author":"Kitashima","year":"2018","journal-title":"EBioMedicine"},{"key":"B138","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12026-010-8191-9","article-title":"Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: Longterm outcomes","volume":"49","author":"Buckley","year":"2011","journal-title":"Immunol Res"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05176.x","article-title":"Severe cutaneous papillomavirus disease after haematopoietic stem-cell transplantation in patients with severe combined immunodeficiency","volume":"127","author":"Bobby Gaspar","year":"2004","journal-title":"Br J Haematol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.98","article-title":"Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature","volume":"2","author":"Zampella","year":"2022","journal-title":"Skin Health Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-515528","article-title":"Gata2 deficiency: A protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12794","article-title":"Generalized verrucosis in a patient with Gata2 deficiency","volume":"170","author":"West","year":"2014","journal-title":"Br J Dermatol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031556","article-title":"Gata-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells","volume":"200","author":"Ling","year":"2004","journal-title":"J Exp Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.10.3636","article-title":"Transcription factor gata-2 is required for Proliferation\/Survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation","volume":"89","author":"Tsai","year":"1997","journal-title":"Blood J Am Soc Hematol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2020.12.028","article-title":"Hematopoietic cell transplantation and outcomes related to human papillomavirus disease in Gata2 deficiency","volume":"27","author":"Parta","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-378158","article-title":"The phenotype of human Stk4 deficiency","volume":"119","author":"Abdollahpour","year":"2012","journal-title":"Blood"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008624","article-title":"Microrna-18a targeting of the Stk4\/Mst1 tumour suppressor is necessary for transformation in hpv positive cervical cancer","volume":"16","author":"Morgan","year":"2020","journal-title":"PloS Pathog"},{"key":"B148","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/tid.12479","article-title":"Human papillomavirus detected in viral warts of renal transplant recipients","volume":"18","author":"Martelli-Marzag\u00e3o","year":"2016","journal-title":"Transplant Infect Dis"},{"key":"B149","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/bmt.2017.210","article-title":"Risks factors and timing of genital human papillomavirus (Hpv) infection in female stem cell transplant survivors: A longitudinal study","volume":"53","author":"Shanis","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B150","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0140-6736(07)61050-2","article-title":"Incidence of cancers in people with Hiv\/Aids compared with immunosuppressed transplant recipients: A meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14181","article-title":"Reactivation of latent hpv infections after renal transplantation","volume":"17","author":"Hinten","year":"2017","journal-title":"Am J Transplant"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13053","article-title":"Cervicovaginal hpv infection in female renal transplant recipients: An observational, self-sampling based, cohort study","volume":"15","author":"Meeuwis","year":"2015","journal-title":"Am J Transplant"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318249b13d","article-title":"Anogenital malignancies in women after renal transplantation over 40 years in a single center","volume":"93","author":"Meeuwis","year":"2012","journal-title":"Transplantation"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv362","article-title":"Long-term Cd4 lymphopenia is associated with accelerated decline of kidney allograft function","volume":"31","author":"Luque","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2009090976","article-title":"Prolonged Cd4 T cell lymphopenia increases morbidity and mortality after renal transplantation","volume":"21","author":"Ducloux","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jncimonographs.a003483","article-title":"Chapter 8: Human papillomavirus and skin cancer","author":"Pfister","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in the Netherlands","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15056","article-title":"Risk of genital warts in renal transplant recipients\u2013a registry-based, prospective cohort study","volume":"19","author":"Larsen","year":"2019","journal-title":"Am J Transplant"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9231031","article-title":"Importance of high-risk human papillomavirus infection detection in female renal transplant recipients in the first year after transplantation","volume":"2018","author":"Cistjakovs","year":"2018","journal-title":"Infect Dis Obstet Gynecol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800810313","article-title":"Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients","volume":"81","author":"Ogunbiyi","year":"1994","journal-title":"J Br Surg"},{"key":"B161","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/00002030-199805000-00011","article-title":"High incidence of anal high-grade squamous intra-epithelial lesions among hiv-positive and hiv-negative homosexual and bisexual men","volume":"12","author":"Palefsky","year":"1998","journal-title":"Aids"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00384-005-0023-3","article-title":"Anal cancer in renal transplant patients","volume":"22","author":"Patel","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/17401","article-title":"Cyclosporine induces cancer progression by a cell-autonomous mechanism","volume":"397","author":"Hojo","year":"1999","journal-title":"Nature"},{"key":"B164","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/01.Tp.0000081399.75231.3b","article-title":"Tacrolimus enhances transforming growth factor-Beta1 expression and promotes tumor progression","volume":"76","author":"Maluccio","year":"2003","journal-title":"Transplantation"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12472","article-title":"Hpv-related cancers after solid organ transplantation in the united states","volume":"13","author":"Madeleine","year":"2013","journal-title":"Am J Transplant"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-012-0195-3","article-title":"Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients","volume":"13","author":"Bangash","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2020.01.112","article-title":"Prevalence of human papillomavirus infection in the head and neck area of patients after kidney transplantation treated with immunosuppressive therapy","volume":"52","author":"Sindrewicz","year":"2020","journal-title":"Transplant Proc"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp205","article-title":"Risk of human papillomavirus-associated cancers among persons with aids","volume":"101","author":"Chaturvedi","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with aids-related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"Jama"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2017.06.002","article-title":"Hpv vaccination of immunocompromised hosts","volume":"4","author":"Garland","year":"2017","journal-title":"Papillomavirus Res"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa166","article-title":"The natural history of anal high-grade squamous intraepithelial lesions in gay and bisexual men","volume":"72","author":"Poynten","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B172","article-title":"Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of papanicolaou smears. new York cervical disease study","volume":"84","author":"Wright","year":"1994","journal-title":"Obstet Gynecol"},{"key":"B173","article-title":"Human papillomavirus and hiv coinfection and the risk of neoplasias of the lower genital tract: A review of recent developments","volume":"169","author":"Ferenczy","year":"2003","journal-title":"Cmaj"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.111791","article-title":"Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus","volume":"184","author":"Duerr","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3018(21)00108-9","article-title":"Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29\u2009900 men according to hiv status, sexuality, and age: A collaborative pooled analysis of 64 studies","volume":"8","author":"Wei","year":"2021","journal-title":"Lancet HIV"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008439","article-title":"Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesions","volume":"5","author":"Cornall","year":"2015","journal-title":"BMJ Open"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26470","article-title":"Prevalence of human papillomavirus in women with invasive cervical carcinoma by hiv status in Kenya and south Africa","volume":"131","author":"Vuyst","year":"2012","journal-title":"Int J Cancer"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.045","article-title":"Human papillomavirus, human immunodeficiency virus and immunosuppression","volume":"30","author":"Denny","year":"2012","journal-title":"Vaccine"},{"key":"B179","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jcv.2004.10.020","article-title":"Therapy for genital human papillomavirus-related disease","volume":"32","author":"Lacey","year":"2005","journal-title":"J Clin Virol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp205","article-title":"Risk of human papillomavirus\u2013associated cancers among persons with aids","volume":"101","author":"Chaturvedi","year":"2009","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200304150-00010","article-title":"Immune deficiency and risk for malignancy among persons with aids","volume":"32","author":"Mbulaiteye","year":"2003","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji073","article-title":"Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus\u2013positive women","volume":"97","author":"Strickler","year":"2005","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000852","article-title":"Exposure to hiv-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation","volume":"6","author":"Nazli","year":"2010","journal-title":"PloS Pathog"},{"key":"B184","article-title":"Reduced Cadherin\/Catenin complex expression in celiac disease can be reproduced in vitro by cytokine stimulation","volume":"79","author":"Perry","year":"1999","journal-title":"Lab Invest"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.071004","article-title":"Transforming growth factor-B1-Mediated slug and snail transcription factor up-regulation reduces the density of langerhans cells in epithelial metaplasia by affecting e-cadherin expression","volume":"172","author":"Herfs","year":"2008","journal-title":"Am J Pathol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00318.2005","article-title":"Molecular mechanism of tumor necrosis factor-A modulation of intestinal epithelial tight junction barrier","volume":"290","author":"Ye","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1038\/nri1860","article-title":"Defensins in innate antiviral immunity","volume":"6","author":"Klotman","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.19.2.305","article-title":"Thrombospondin-1 and-2 messenger rna expression in invasive cervical cancer: Correlation with angiogenesis and prognosis","volume":"7","author":"Kodama","year":"2001","journal-title":"Clin Cancer Res"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7646com","article-title":"Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated (Pre) neoplastic lesions formed in vitro and transplanted in vivo","volume":"21","author":"Hubert","year":"2007","journal-title":"FASEB J"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5439.525","article-title":"B-defensins: Linking innate and adaptive immunity through dendritic and T cell Ccr6","volume":"286","author":"Yang","year":"1999","journal-title":"Science"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666170704130635","article-title":"The hiv-1 tat protein: Mechanism of action and target for hiv-1 cure strategies","volume":"23","author":"Rice","year":"2017","journal-title":"Curr Pharm Des"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00650-11","article-title":"The hiv-1 tat protein has a versatile role in activating viral transcription","volume":"85","author":"Das","year":"2011","journal-title":"J Virol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.08.018","article-title":"Hiv-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus","volume":"446","author":"Tugizov","year":"2013","journal-title":"Virology"},{"key":"B194","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000150322","article-title":"Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression","volume":"36","author":"Tornesello","year":"1993","journal-title":"Intervirology"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4921","article-title":"Entrance of the tat protein of hiv-1 into human uterine cervical carcinoma cells causes upregulation of hpv-E6 expression and a decrease in P53 protein levels","volume":"12","author":"Barillari","year":"2016","journal-title":"Oncol Lett"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000064","article-title":"Hiv-1 tat enhances replicative potential of human oral keratinocytes harboring hpv-16 genome","volume":"33","author":"Kim","year":"2008","journal-title":"Int J Oncol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.5.6.2907","article-title":"The effects of hiv-1 tat protein on cell cycle during cervical carcinogenesis","volume":"5","author":"Nyagol","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1042\/cbi20090376","article-title":"Hiv-1 tat is unconventionally secreted through the plasma membrane","volume":"34","author":"Rayne","year":"2010","journal-title":"Cell Biol Int"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282ed6338","article-title":"Risk of cancers during interrupted antiretroviral therapy in the smart study","volume":"21","author":"Silverberg","year":"2007","journal-title":"Aids"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm010","article-title":"Aids-related cancer and severity of immunosuppression in persons with aids","volume":"99","author":"Biggar","year":"2007","journal-title":"J Natl Cancer Institute"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1086\/650467","article-title":"Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus\u2013positive women","volume":"201","author":"Minkoff","year":"2010","journal-title":"J Infect Dis"},{"key":"B202","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/CCO.0b013e32836242b4","article-title":"Oral hpv infection and head and neck cancers in hiv-infected individuals","volume":"25","author":"Beachler","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.18.2187","article-title":"Cd4 T-lymphocyte recovery in individuals with advanced hiv-1 infection receiving potent antiretroviral therapy for 4 years: The Swiss hiv cohort study","volume":"163","author":"Kaufmann","year":"2003","journal-title":"Arch Internal Med"},{"key":"B204","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/154407370601900120","article-title":"Biology of hpv in hiv infection","volume":"19","author":"Palefsky","year":"2006","journal-title":"Adv Dental Res"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1086\/338637","article-title":"Human papillomavirus\u2013associated oral warts among human immunodeficiency virus\u2013seropositive patients in the era of highly active antiretroviral therapy: An emerging infection","volume":"34","author":"King","year":"2002","journal-title":"Clin Infect Dis"},{"key":"B206","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2133.2009.09365.x","article-title":"Human papillomavirus in the era of highly active antiretroviral therapy for human immunodeficiency virus: An immune reconstitution-associated disease","volume":"162","author":"Meys","year":"2010","journal-title":"Br J Dermatol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050346","article-title":"Association of genital human papillomavirus infection with hiv acquisition: A systematic review and meta-analysis","volume":"89","author":"Lissouba","year":"2013","journal-title":"Sexually Transmitted Infect"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328358d908","article-title":"Hpv infection and increased risk of hiv acquisition. a systematic review and meta-analysis","volume":"26","author":"Houlihan","year":"2012","journal-title":"AIDS (Lond Engl)"},{"key":"B209","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/qad.0b013e3283377973","article-title":"The association between cervical hpv infection and hiv acquisition among women in Zimbabwe","volume":"24","author":"Averbach","year":"2010","journal-title":"AIDS (Lond Engl)"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1086\/652408","article-title":"Increased risk of hiv acquisition among Kenyan men with human papillomavirus infection","volume":"201","author":"Smith","year":"2010","journal-title":"J Infect Dis"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/QAD.0b013e32832b4449","article-title":"Anal human papillomavirus infection is associated with hiv acquisition in men who have sex with men","volume":"23","author":"Chin-Hong","year":"2009","journal-title":"AIDS (London England)"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101836","article-title":"Characterization of a human cervical Cd4+ T cell subset coexpressing multiple markers of hiv susceptibility","volume":"187","author":"McKinnon","year":"2011","journal-title":"J Immunol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/mi.2015.51","article-title":"Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of hiv-susceptible target cells","volume":"9","author":"Arnold","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ298","article-title":"Genital inflammation and the risk of hiv acquisition in women","volume":"61","author":"Masson","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13089-2","article-title":"Hpv infection and the genital cytokine milieu in women at high risk of hiv acquisition","volume":"10","author":"Liebenberg","year":"2019","journal-title":"Nat Commun"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3182","article-title":"Cxcr4: A key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2007.02.012","article-title":"Dichotomous effects of c\u2013c chemokines in hiv-1 pathogenesis","volume":"110","author":"Ansari","year":"2007","journal-title":"Immunol Lett"},{"key":"B218","doi-asserted-by":"publisher","first-page":"101427","DOI":"10.1016\/j.isci.2020.101427","article-title":"Hiv-captured dcs regulate T cell migration and cell-cell contact dynamics to enhance viral spread","volume":"23","author":"Koh","year":"2020","journal-title":"Iscience"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422x-9-262","article-title":"A review of methods for detect human papillomavirus infection","volume":"9","author":"Abreu","year":"2012","journal-title":"Virol J"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.864820","article-title":"Molecular detection methods in hpv-related cancers","volume":"12","author":"Williams","year":"2022","journal-title":"Front Oncol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205214","article-title":"Involvement of intact Hpv16 E6\/E7 gene expression in head and neck cancers with unaltered P53 status and perturbed prb cell cycle control","volume":"21","author":"Wiest","year":"2002","journal-title":"Oncogene"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.132.4.409","article-title":"Fine-mapping loss of gene architecture at the Cdkn2b (P15ink4b), Cdkn2a (P14arf, P16ink4a), and mtap genes in head and neck squamous cell carcinoma","volume":"132","author":"Worsham","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.23.1670","article-title":"Comparative prognostic value of Hpv16 E6 mrna compared with in situ hybridization for human oropharyngeal squamous carcinoma","volume":"27","author":"Shi","year":"2009","journal-title":"J Clin Oncol"},{"key":"B224","volume-title":"Cervical cancer","year":"2022"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with hiv","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0b013e3282f75ea1","article-title":"Hiv, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy","volume":"17","author":"De Vuyst","year":"2008","journal-title":"Eur J Cancer Prev"},{"key":"B227","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"Clinical practice guideline for the care of kidney transplant recipients","year":"2009","journal-title":"Am J Transplant"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"B229","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ijc.28963","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","author":"Alemany","year":"2015","journal-title":"Int J Cancer"},{"key":"B230","article-title":"Anal intraepitelial neoplasia: A narrative review","volume":"108","author":"Elorza","year":"2016","journal-title":"Rev Esp Enferm Dig"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-398","article-title":"Hpv infection, anal intra-epithelial neoplasia (Ain) and anal cancer: Current issues","volume":"12","author":"Stanley","year":"2012","journal-title":"BMC Cancer"},{"key":"B232","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/s1470-2045(12)70080-3","article-title":"Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis","volume":"13","author":"Machalek","year":"2012","journal-title":"Lancet Oncol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973-2000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328331d384","article-title":"Continuing declines in some but not all hiv-associated cancers in Australia after widespread use of antiretroviral therapy","volume":"23","author":"van Leeuwen","year":"2009","journal-title":"Aids"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1056\/nejm198710153171601","article-title":"Sexual practices, sexually transmitted diseases, and the incidence of anal cancer","volume":"317","author":"Daling","year":"1987","journal-title":"N Engl J Med"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: A nationwide cohort study in Sweden","volume":"89","author":"Adami","year":"2003","journal-title":"Br J Cancer"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e31819793d9","article-title":"Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia","volume":"52","author":"Berry","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/806345","article-title":"Human papillomavirus and oropharyngeal squamous cell carcinoma: A case-control study regarding tobacco and alcohol consumption","volume":"2011","author":"Farshadpour","year":"2011","journal-title":"Patholog Res Int"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31383","article-title":"A snapshot of the evolving epidemiology of oropharynx cancers","volume":"124","author":"Chaturvedi","year":"2018","journal-title":"Cancer"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.098","article-title":"Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets","volume":"28","author":"Hong","year":"2010","journal-title":"Vaccine"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00603-7","article-title":"Hpv-associated oropharyngeal cancer: Epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit170","article-title":"Natural history of anal vs oral hpv infection in hiv-infected men and women","volume":"208","author":"Beachler","year":"2013","journal-title":"J Infect Dis"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000452","article-title":"Cd103+ tumor-resident Cd8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma","volume":"8","author":"Hewavisenti","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.01.003","article-title":"Anogenital malignancies and premalignancies: Facts and controversies","volume":"31","author":"Kutlubay","year":"2013","journal-title":"Clin Dermatol"},{"key":"B245","article-title":"Vulvar neoplasia in hiv positive women: A review","volume":"7","author":"Casolati","year":"2003","journal-title":"Med Wieku Rozwoj"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.18.1500","article-title":"Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"92","author":"Frisch","year":"2000","journal-title":"J Natl Cancer institute"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1089\/apc.1998.12.251","article-title":"Vulvar intraepithelial neoplasia in women with hiv","volume":"12","author":"Abercrombie","year":"1998","journal-title":"AIDS Patient Care STDS"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0161","article-title":"Vulvar intraepithelial neoplasia in women infected with human immunodeficiency virus-1","volume":"61","author":"Korn","year":"1996","journal-title":"Gynecol Oncol"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652054","article-title":"Immunotherapy advances in locally advanced and Recurrent\/Metastatic head and neck squamous cell carcinoma and its relationship with human papillomavirus","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B250","doi-asserted-by":"publisher","first-page":"55600","DOI":"10.18632\/oncotarget.16340","article-title":"Locoregionally recurrent head and neck squamous cell carcinoma: Incidence, survival, prognostic factors, and treatment outcomes","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23136","article-title":"Transoral resection of pharyngeal cancer: Summary of a national cancer institute head and neck cancer steering committee clinical trials planning meeting, November 6-7, 2011, Arlington, Virginia","volume":"34","author":"Adelstein","year":"2012","journal-title":"Head Neck"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2003.01.008","article-title":"An intergroup phase iii comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7090241","article-title":"A review of hpv-related head and neck cancer","volume":"7","author":"Kobayashi","year":"2018","journal-title":"J Clin Med"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (Keynote-012): An open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (Keynote-048): A randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"B257","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: Results from the phase 2 keynote-158 study","volume":"37","author":"Ros","year":"2019","journal-title":"Early Phase Clin Stud Novel Immunother Oncol"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(21)00382-4","article-title":"Pembrolizumab for previously treated advanced anal squamous cell carcinoma: Results from the non-randomised, multicohort, multicentre, phase 2 keynote-158 study","volume":"7","author":"Marabelle","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx029","article-title":"Safety and antitumor activity of the anti-Pd-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal","volume":"28","author":"Ott","year":"2017","journal-title":"Ann Oncol"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00914","article-title":"High-risk hpv oncoproteins and pd-1\/Pd-L1 interplay in human cervical cancer: Recent evidence and future directions","volume":"10","author":"Allouch","year":"2020","journal-title":"Front Oncol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000000071","article-title":"Malignancies in Hiv\/Aids: From epidemiology to therapeutic challenges","volume":"28","author":"Rubinstein","year":"2014","journal-title":"Aids"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32832f3e04","article-title":"Targeted therapies to treat non-Aids-Defining cancers in patients with hiv on haart therapy: Treatment considerations and research outlook","volume":"21","author":"Deeken","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.01.074","article-title":"Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 Years of age compared to women 16-26 Years of age: An open-label phase 3 study","volume":"39","author":"Joura","year":"2021","journal-title":"Vaccine"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23764","article-title":"Hpv prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","author":"Gillison","year":"2008","journal-title":"Cancer"},{"key":"B266","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (Acip)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"B267","article-title":"Meeting of the strategic advisory group of experts on immunization, April 2014\u2013conclusions and recommendations","volume":"89","year":"2014","journal-title":"Weekly Epidemiol Rec"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"Hpv vaccination introduction worldwide and who and unicef estimates of national hpv immunization coverage 2010\u20132019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev Med"},{"key":"B269","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0929-6646(10)60017-4","article-title":"Perspectives for preventive and therapeutic hpv vaccines","volume":"109","author":"Lin","year":"2010","journal-title":"J Formos Med Assoc"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-Like-Particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomised clinical trials","volume":"369","author":"Ault","year":"2007","journal-title":"Lancet"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1136039","article-title":"Current therapeutic vaccination and immunotherapy strategies for hpv-related diseases","volume":"12","author":"Skeate","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.02424","article-title":"T-Cell receptor gene therapy for human papillomavirus\u2013associated epithelial cancers: A first-in-Human, phase I\/Ii study","volume":"37","author":"Doran","year":"2019","journal-title":"J Clin Oncol"},{"key":"B273","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/cji.0000000000000386","article-title":"Potent, selective cars as potential T-cell therapeutics for hpv-positive cancers","volume":"44","author":"Wang","year":"2021","journal-title":"J Immunother"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-15-0190","article-title":"T-Cell-Based immunotherapy: Adoptive cell transfer and checkpoint inhibition","volume":"3","author":"Houot","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B275","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/13543784.2021.2010703","article-title":"Hpv-induced cancers: Preclinical therapeutic advancements","volume":"31","author":"Messa","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mrna-1273 sars-Cov-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the Bnt162b2 mrna covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243","article-title":"Mrna vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discovery"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2019.10.002","article-title":"Tailoring mrna vaccine to balance Innate\/Adaptive immune response","volume":"26","author":"Linares-Fern\u00e1ndez","year":"2020","journal-title":"Trends Mol Med"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"Mrna vaccines manufacturing: Challenges and bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"key":"B281","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41467-019-08867-x","article-title":"Diversifying the structure of zinc finger nucleases for high-precision genome editing","volume":"10","author":"Paschon","year":"2019","journal-title":"Nat Commun"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-14-0250","article-title":"Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in Hpv16\/18-positive cervical cancer cells","volume":"20","author":"Ding","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1410","article-title":"Establishment of hiv-1 resistance in Cd4+ T cells by genome editing using zinc-finger nucleases","volume":"26","author":"Perez","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1172\/jci72992","article-title":"Expanding the genetic editing tool kit: Zfns, talens, and crispr-Cas9","volume":"124","author":"Gupta","year":"2014","journal-title":"J Clin Invest"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1016\/j.jplph.2018.04.001","article-title":"Crispr\/Cas approach: A new way of looking at plant-abiotic interactions","author":"Mushtaq","year":"2018","journal-title":"J Plant Physiol"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1993.tb01721.x","article-title":"Transcription at different salinities of haloferax mediterranei sequences adjacent to partially modified psti sites","volume":"9","author":"Mojica","year":"1993","journal-title":"Mol Microbiol"},{"key":"B287","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4939-2687-9_4","article-title":"Annotation and classification of crispr-cas systems","volume":"1311","author":"Makarova","year":"2015","journal-title":"Methods Mol Biol"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2018.1504546","article-title":"Pam Identification by crispr-cas effector complexes: Diversified mechanisms and structures","volume":"16","author":"Gleditzsch","year":"2019","journal-title":"RNA Biol"},{"key":"B289","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41556-020-00620-7","article-title":"Crispr technologies for precise epigenome editing","volume":"23","author":"Nakamura","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B290","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1038\/s41467-019-11105-z","article-title":"Stimulation of crispr-mediated homology-directed repair by an engineered Rad18 variant","volume":"10","author":"Nambiar","year":"2019","journal-title":"Nat Commun"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201700540","article-title":"Hpv oncogene manipulation using nonvirally delivered Crispr\/Cas9 or natronobacterium gregoryi argonaute","volume":"5","author":"Lao","year":"2018","journal-title":"Adv Sci (Weinh)"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.07.014","article-title":"In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by Crispr\/Cas9","volume":"450","author":"Zhen","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1038\/sj.neo.7900101","article-title":"Cell cycle and apoptosis","volume":"2","author":"Pucci","year":"2000","journal-title":"Neoplasia"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00424","article-title":"Block and lock hiv cure strategies to control the latent reservoir","volume":"10","author":"Ahlenstiel","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.31","article-title":"Novel rna duplex locks hiv-1 in a latent state Via chromatin-mediated transcriptional silencing","volume":"4","author":"Ahlenstiel","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205878","article-title":"Selective silencing of viral gene expression in hpv-positive human cervical carcinoma cells treated with sirna, a primer of rna interference","volume":"21","author":"Jiang","year":"2002","journal-title":"Oncogene"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"Rna-targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metab"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206894","article-title":"Sirna targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells","volume":"22","author":"Butz","year":"2003","journal-title":"Oncogene"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.06.033","article-title":"Gene silencing with sirna targeting E6\/E7 as a therapeutic intervention in a mouse model of cervical cancer","volume":"111","author":"Jonson","year":"2008","journal-title":"Gynecol Oncol"},{"key":"B300","article-title":"In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes","volume":"55","author":"Tan","year":"1995","journal-title":"Cancer Res"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0310","article-title":"Adenovirus-mediated transfer of hpv 16 E6\/E7 antisense rna to human cervical cancer cells","volume":"63","author":"Hamada","year":"1996","journal-title":"Gynecol Oncol"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1089\/oli.1.1999.9.441","article-title":"Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene","volume":"9","author":"Alvarez-Salas","year":"1999","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"B303","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/gyno.2000.5916","article-title":"Retrovirus-mediated delivery of Hpv16 E7 antisense rna inhibited tumorigenicity of caski cells","volume":"78","author":"Choo","year":"2000","journal-title":"Gynecol Oncol"},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw139","article-title":"Transcriptional gene silencing in humans","volume":"44","author":"Weinberg","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.10.107","article-title":"Human papillomavirus: Gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies","volume":"5","author":"Graham","year":"2010","journal-title":"Future Microbiol"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-09-0977","article-title":"Silencing of integrated human papillomavirus-16 oncogenes by small interfering rna-mediated heterochromatization","volume":"9","author":"Palanichamy","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"B307","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12967-015-0602-1","article-title":"A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [Corrected]","volume":"13","author":"Khan","year":"2015","journal-title":"J Transl Med"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2011.9","article-title":"The business of rnai therapeutics in 2012","volume":"1","author":"Haussecker","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-017-9717-6","article-title":"Rna interference-based therapy and its delivery systems","volume":"37","author":"Chen","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2020.1835306","article-title":"Cost savings with hemin versus givosiran for the treatment of patients with acute intermittent porphyria (Aip)","volume":"23","author":"Massachi","year":"2020","journal-title":"J Med Econ"},{"key":"B311","volume-title":"Pharmacoeconomic review report: Patisiran (Onpattro): (Alnylam Netherlands bv): Indication: Treatment of polyneuropathy in adult patients with hereditary transthyretin-mediated amyloidosis","year":"2019"},{"key":"B312","unstructured":"Conference call to discuss fda approval of amvuttra2023"},{"key":"B313","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.07.008","article-title":"A simple and cost-effective approach for In vitro production of sliced sirnas as potent triggers for rnai","volume":"8","author":"Sun","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"B314","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40035-017-0101-9","article-title":"Rnai mechanisms in huntington's disease therapy: Sirna versus shrna","volume":"6","author":"Aguiar","year":"2017","journal-title":"Transl Neurodegener"},{"key":"B315","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174178","article-title":"Sirna: Mechanism of action, challenges, and therapeutic approaches","volume":"905","author":"Alshaer","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"B316","doi-asserted-by":"publisher","DOI":"10.3390\/nano7040077","article-title":"Sirna delivery strategies: A comprehensive review of recent developments","volume":"7","author":"Tatiparti","year":"2017","journal-title":"Nanomaterials (Basel)"},{"key":"B317","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2012.36","article-title":"Regulation of small rna stability: Methylation and beyond","volume":"22","author":"Ji","year":"2012","journal-title":"Cell Res"},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2020.09.011","article-title":"Rnai therapeutics: An antiviral strategy for human infections","volume":"54","author":"Kelleher","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"B319","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/pharmaceutics5030498","article-title":"Advances in lipid nanoparticles for sirna delivery","volume":"5","author":"Tam","year":"2013","journal-title":"Pharmaceutics"},{"key":"B320","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an rnai therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"B321","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01463-0","article-title":"Lumasiran: First approval","volume":"81","author":"Scott","year":"2021","journal-title":"Drugs"},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated ldl cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"key":"B323","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13506129.2022.2091985","article-title":"Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: A randomized clinical trial","author":"Adams","year":"2022","journal-title":"Amyloid"},{"key":"B324","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913147","article-title":"Phase 3 trial of rnai therapeutic givosiran for acute intermittent porphyria","volume":"382","author":"Balwani","year":"2020","journal-title":"N Engl J Med"},{"key":"B325","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2018.0736","article-title":"Galnac-sirna conjugates: Leading the way for delivery of rnai therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Ther"},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-237-3_18","article-title":"Lentiviral vector delivery of sirna and shrna encoding genes into cultured and primary hematopoietic cells","volume":"433","author":"Li","year":"2008","journal-title":"Methods Mol Biol"},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2397","article-title":"Gene silencing by lentivirus-mediated delivery of sirna in human Cd34+ cells","volume":"103","author":"Schomber","year":"2004","journal-title":"Blood"},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous ex vivo lentiviral gene therapy for adenosine deaminase deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N Engl J Med"},{"key":"B329","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S180962","article-title":"Lentivirus-mediated sirna knockdown of Sphk1 inhibits proliferation and tumorigenesis of neuroblastoma","volume":"11","author":"Su","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B330","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700971","article-title":"Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin rna targeting human papillomavirus E6 and E7 oncogenes","volume":"13","author":"Gu","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"B331","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.05.019","article-title":"Efficient nuclease-directed integration of lentivirus vectors into the human ribosomal DNA locus","volume":"28","author":"Schenkwein","year":"2020","journal-title":"Mol Ther"},{"key":"B332","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001197","article-title":"Outcomes of kidney transplantation in hiv-infected recipients","volume":"363","author":"Stock","year":"2010","journal-title":"N Engl J Med"},{"key":"B333","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0359-1","article-title":"Local heroes or villains: Tissue-resident memory T cells in human health and disease","volume":"17","author":"Sasson","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B334","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-021-00366-w","article-title":"The application of Crispr\/Cas9 system in cervical carcinogenesis","volume":"29","author":"Gao","year":"2022","journal-title":"Cancer Gene Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1112513\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:17:48Z","timestamp":1678148268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1112513\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":334,"alternative-id":["10.3389\/fimmu.2023.1112513"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1112513","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"article-number":"1112513"}}